Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion

Vascular

Volumn 4, Issue 3, 1996, Pages 399-404

  Gennaro, M ^a   Mohan, C ^a   Ascer, E ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

perfluorocarbons; reperfusion injury; thromboxane

Indexed keywords

FLUOROCARBON; FLUOSOL DA; ICOSANOID; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; EMULSION; GRACILIS MUSCLE; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE ISCHEMIA; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SKELETAL MUSCLE; VASOSPASM;

EID: 0029976930     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099600400328     Document Type: Article

References (44)

1. Haimovici H. Metabolic complications of acute arterial occlusions. J Cardiovasc Surg (Torino) 1979; 20: 349–357.
2. Haimovici H. Arterial embolism with acute massive ischemic myopathy and myoglobinuria. Surgery 1960; 116: 414–421.
3. Cormier JM, Legrain M. L'hyperkaliemie, complication très grave des syndromes d'ischemie aigue des membres. J Chir (Paris) 1962; 83: 473–483.
4. Harris K, Walker PM, Mickle DAG, et al. Metabolic response of skeletal muscle to ischemia. Am J Physiol 1986; 250: H213–20.
5. Del Maestro RF, Bjork J, Arfors KE. Increase in microvascular permeability induced by enzymatically generated free radicals. Microvasc Res 1981; 22: 239–254.
6. Korthius RJ, Granger DN, Townsley ML, Taylor AE. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 1985; 57: 599–609.
7. Belkin M, LaMorte WL, Wright JG, Hobson RW. The role of leukocytes in the pathophysiology of skeletal muscle ischemic injury. J Vasc Surg 1989; 10: 14–19.
8. Smith JK, Grisham MB, Granger DN, Korthius RJ. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol 1989; 256: H789–93.
9. Rubin BB, Smith A, Liauw S, Isenman D, Romaschin AD, Walker PM. Complement activation and white cell sequestration in postischemic skeletal muscle. Am J Physiol 1990; 259: H525–31.
10. Anderson RJ, Cambria RA, Dikdan G, Lysz TW, Hobson RW. Role of eicosanoids and white blood cells in the beneficial effects of limited reperfusion after ischemia-reperfusion injury in skeletal muscle. Am J Surg 1990; 160: 151–155.
11. Lelcuk S, Alexander F, Valeri R, Shepro D, Hechtman HB. Thromboxane A2 moderates permeability after limb ischemia. Ann Surg 1985; 202: 642–646.
12. Anner H, Kaufman RP, Kobzik L, Valeri R, Shepro D, Hechtman HB. Pulmonary leukosequestration induced by hind limb ischemia. Ann Surg 1987; 206: 162–167.
13. Klausner JM, Paterson IS, Valeri R, Shepro D, Hechtman HB. Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes. Ann Surg 1988; 208: 755–760.
14. Parks DA, Granger DN. Ischemia-induced vascular changes: Role of xanthine oxidase and hydroxyl radicals. Am J Physiol 1983; 245: G285–9.
15. Walker PM, Lindsay TF, Labbe R, Mickle DA, Romaschin AD. Salvage of skeletal muscle with free radical scavengers. J Vasc Surg 1987; 5: 68–75.
16. Haimovici H. Metabolic complications of acute arterial occlusions. J Cardiovasc Surg (Torino) 1979; 20: 349–357.
17. Ascer E, Mohan C, Gennaro M, Cupo S. Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion. Ann Vasc Surg 1992; 6: 69–73.
18. Jolly SR, Kane WJ, Baillie MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury; its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984; 54: 277–285.
19. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork A, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67: 1016–1023.
20. Rubin B, Tittley J, Chang G, et al. A clinically applicable method for long-term salvage of post-ischemic skeletal muscle. J Vasc Surg 1991; 3: 58–68.
21. Blebea J, Cambria RA, DeFouw D, Feinberg RN, Hobson RW, Duran WN. Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion. J Vasc Surg 1990; 12: 657–666.
22. Wright JG, Fox D, Kerr JC, Valeri CR, Hobson RW. Rate of reperfusion blood flow modulates reperfusion injury in skeletal muscle. J Surg Res 1988; 44: 754–763.
23. Mohan C, Gennaro M, Marini C, Ascer E. Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon. Am J Surg 1992; 164: 194–198.
24. Doukas J, Hechtman HB, Shepro D. Endothelial-secreted arachidonic acid metabolites modulate polymorphonuclear leukocyte Chemotaxis and diapedesis in vitro. Blood 1988; 71: 771–779.
25. Paterson IS, Klausner JM, Kobzik L, et al. Thromboxane mediates the ischemia induced neutrophil oxidative burst. Surgery 1989; 106: 224–229.
26. Kuzon WM, Walker PM, Mickle DAG, Harris KA, Pynn BR, McKee NH. An isolated skeletal muscle model suitable for acute ischemia studies. J Surg Res 1986; 41: 24–32.
27. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 251: G567–74.
28. Cambria RA, Anderson RJ, Dikdan G, Teehan EP, Maldonado-Hernandez JJ, Hobson RW II. Leukocyte activation in ischemia-reperfusion injury of skeletal muscle. J Surg Res 1991; 51: 13–17.
29. Tonneson MG. Neutrophil-endothelial cell interactions: Mechanisms of neutrophil adherence to vascular endothelium. J Invest Dermatol 1989; 93 (Suppl. 2): S53–8.
30. Korthius RJ, Granger DN. In Taylor AE, Matalon K, Ward PA, eds. Physiology of Oxygen Radicals. Bethesda, Maryland: American Physiological Society, 1986: 217–249.
31. Anner H, Kaufman RP, Kobzik L, Valeri R, Shepro D, Hechtman HB. Pulmonary hypertension and leukosequestration after lower torso ischemia. Ann Surg 1987; 206: 642–648.
32. Goldman G, Welbourn R, Klausner JM, Valeri CR, Shepro D, Hechtman HB. Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. Circ Res 1991; 68: 1013–1019.
33. De La Ossa JC, Malago M, Gewertz BL. Neutrophil-endothelial cell binding in neutrophil-mediated tissue injury. J Surg Res 1992; 53: 103–107.
34. Luscinskas FW, Brock AF, Arnaout MA, Gimbrone MA. Endothelial—leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18) dependent mechanism contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol 1989; 142: 2257–2263.
35. Choudbury NA, Koyano K, Matin AFM, Muro H. Free radical injury in skeletal muscle ischemia and reperfusion. J Surg Res 1991; 51: 392–398.
36. Anderson RJ, Cambria R, Kerr J, Hobson RW II. Sustained benefit of temporary limited reperfusion in skeletal muscle following ischemia. J Surg Res 1990; 49: 271–277.
37. Belkin M, Wright G, Hobson RW II. Iloprost infusion decreases skeletal muscle ischemia-reperfusion. J Vasc Surg 1990; 11: 77–83.
38. Forman MB, Bingham SE, Kopelman HA, et al. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation. Circulation 1985; 71: 1060–1068.
39. Forman MB, Puett DW, Bingham SE, et al. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1987; 76: 469–479.
40. Bajaj AK, Cobb MA, Virmani R, Gay JC, Light RT, Forman MB. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals; role of neutrophil activation. Circulation 1989; 79: 645–656.
41. Forman MB, Puett DW, Wilson BH, et al. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model. J Am Coll Cardiol 1987; 9: 1082–1090.
42. Klausner AM, Anner H, Paterson IS, et al. Lower torso ischemia induced lung injury is leukocyte dependent. Ann Surg 1988; 208: 761–767.
43. Halushka PV, Lefer AM. Thromboxane A2 in health and disease. Fed Proc 1987; 461: 131–132.
44. Cambria RA, Anderson RJ, Dikdan G, Lysz TW, Hobson RW II. Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia. Am Surg 1991; 57: 76–79.